Western blot analysis of Caspase expression in human Jurkat cells. The blot was probed with anti-Caspase-3 at 1:500 (lane 1) and 1:1000 (lane 2), anti-Caspase-6 at 1:250 (lane 3) and 1:500 (lane 4), anti-Caspase-7 at 1:500 (lane 5) and 1:1000 (lane 6), as well as anti-Caspase-8 at 1:250 (lane 7) and 1:500 (lane 8).
Anti-Caspase-3 (N-terminal region) Antibody
SKU: CM3771
Bulk Order Anti-Caspase-3 (N-terminal region) Antibody
Product Details
Caspase-3 (N-terminal region)
The caspases are a group of cysteine enzymes, which cleave proteins in response to intrinsic and extrinsic pathways that cause apoptotic cell death. The caspases can be grouped into two subgroups based on their roles in apoptosis. Initiator caspases (caspases 2, 8, 9, and 10) are activated through the apoptosis-signaling pathways and activate the effector caspases (caspases 3, 6, and 7) which carry out apoptosis. Caspase cascades are initiated through assembly of multiprotein complexes that trigger activation of the initiator caspases, which are then released and are able to activate the downstream effector caspases.
Protein A Purified
Monoclonal
M377
IgG2a
ICC, WB
Mouse
CASP3
32
Clone (M377) was generated from a recombinant protein containing amino acid residues in the N-terminal region of human Caspase-3.
Human
Storage at -20°C is recommended, as aliquots may be taken without freeze/thawing due to presence of 50% glycerol. Stable for at least 1 year at -20°C.
Liquid
PBS + 1 mg/ml BSA, 0.05% NaN3 and 50% glycerol
WB: 1:1000
ICC: 1:100
Unconjugated
The antibody detects a 32 kDa* protein corresponding to the molecular weight of Caspase-3 on SDS-PAGE immunoblots of human Jurkat and K562 cells.
Western blots performed on each lot.
For research use only. Not intended for therapeutic or diagnostic use. Use of all products is subject to our terms and conditions, which can be viewed on our website.
United States
After date of receipt, stable for at least 1 year at -20°C.
Masilamani, AP, et al. 2023. Enhanced Cytotoxicity of a Pseudomonas Exotoxin A Based Immunotoxin Against Prostate Cancer by Addition of the Endosomal Escape Enhancer SO1861. Frontiers in Pharmacology, 1211824.
Related Products
Recently Viewed
We stand by what we sell.
We are proud of every product that leaves our lab.
Support from the source.
No one knows our products like us, and we want you to succeed.
